20030105
 Stimulant Treatment For Hyperactivity Gets Favorable Result   By Reuters News Service, The Wall Street Journal,  Jan 6, 2003  The study done at the University of Massachusetts Medical School and the Medical College of Wisconsin covered 147 hyperactive children who were followed for 13 years into adulthood. Some were treated with stimulants, primarily methylphenidate, the ingredient in the popular Ritalin brand marketed by Swiss-based Novartis AG.   
